ArticleAesthetic plastic surgery2026
Social Media Use Among Plastic Surgeons in China: A National Cross-Sectional Survey of Professional Benefits, Ethical Risks, and Platform-Specific Challenges.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe rapid expansion of social media has significantly altered the landscape of patient communication, professional branding, and ethical practice in plastic surgery. In China, where the aesthetic medicine market is growing rapidly, surgeons increasingly rely on platforms such as Xiaohongshu and Douyin to engage with patients. However, the implications of this digital transformation for clinical practice remain insufficiently explored.
methodsA national cross-sectional survey of 800 licensed plastic surgeons was conducted from December 2024 to March 2025. The questionnaire assessed platform usage, perceived benefits, patient interactions, and ethical concerns. Data were analyzed using descriptive statistics and correlation analysis.
resultsWeChat Video (62.75%) and Xiaohongshu (61.13%) were the most utilized platforms. A majority reported enhanced professional visibility (84.00%) and income growth (57.50%), though 52.87% attributed ≤ 10% of income to social media. Key challenges included unrealistic patient expectations (69.43%), negative feedback (62.18%), and exposure to misleading advertisements (76.68%). Platform-specific risks emerged: Douyin was associated with privacy breaches (p = 0.015) and patient dissatisfaction (p = 0.008), while Xiaohongshu correlated with patient acquisition (p < 0.001). Subgroup analyses suggested heterogeneous patterns across experience levels and institution types, with private-sector surgeons with 6-10 years of experience reporting consistently favorable social media-related outcomes.
conclusionsSocial media was perceived as a useful adjunct for professional visibility, patient communication, and practice development among Chinese plastic surgeons. Its use was also associated with ethical and operational challenges, including unrealistic expectations, privacy concerns, misinformation, and patient dissatisfaction. These association-based findings support the need for platform-specific guidance, transparent risk disclosure, and stronger privacy safeguards in digital aesthetic practice. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42443421What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.